• The Korea Genome Conference
• /
• 2006.09a
• /
• pp.48-48
• /
• 2006

• Clinical and Experimental Reproductive Medicine
• /
• v.35 no.4
• /
• pp.239-245
• /
• 2008

• 대한생식의학회:학술대회논문집
• /
• 2006.06a
• /
• pp.18-20
• /
• 2006

• The Korea Genome Conference
• /
• 2005.09a
• /
• pp.48-48
• /
• 2005

• Journal of Menopausal Medicine
• /
• v.24 no.3
• /
• pp.196-203
• /
• 2018

Objectives: This study was aimed to establish the most effective premature ovarian failure (POF) mouse model using Cyclophosphamide (CTX), busulfan (Bu), and cisplatin considering treatment duration of anticancer drugs and natural recovery time. Methods: POF was induced by intraperitoneally injecting CTX (120 mg/kg)/Bu (12 mg/kg) for 1 to 4 weeks or cisplatin (2 mg/kg) for 3 to 14 days to C57BL/6 female mice aged 6 to 8 weeks. Controls were injected with equal volume of saline for the same periods. Body weight was measured every week, and ovarian and uterine weights were measured after the last injection of anticancer drug. To assess ovarian function, POF-induced mice were superovulated with pregnant mare serum gonadotropin and human chorionic gonadotropin, and then mated with male. After 18 hours, zygotes were retrieved and cultured for 4 days. Finally, the mice were left untreated for a period of times after the final injection of anticancer drug, and the time for natural recovery of ovarian function was evaluated. Results: After 2 weeks of CTX/Bu injection, ovarian and uterine weights, and ovarian function were decreased sharply. Cisplatin treatment for 10 days resulted in a significant decrease in ovarian and uterine weight, and ovarian function. When POF was induced for at least 2 weeks for CTX/Bu and for at least 10 days for cisplatin, ovarian function did not recover naturally for 2 weeks and 1 week, respectively. Conclusions: These results suggest that CTX/Bu should be treated for at least 2 weeks and cisplatin for at least 10 days to establish the most effective primary ovarian insufficiency mouse model.

• The Journal of Korean Obstetrics and Gynecology
• /
• v.35 no.1
• /
• pp.12-33
• /
• 2022

Objectives: Since the importance of Korean Medicine (KM) treatment for Poor Ovarian Response (POR) is high, we intend to present appropriate treatment standards and methods by analyzing information on KM knowledge presented in related research papers and literature. Methods: First, research papers dealing with Diminished Ovarian Reserve (DOR) and POR are analyzed. In addition, we analyze and refer to research papers on Premature Ovarian Failure and Premature Menopause, which are closely related to DOR. Results: It is considered that the application of KM treatment alone for DOR should be based on the age that best reflects the ovarian reserve rather than the value of the ovarian reserve-related index centered on Anti-Müllerian Hormine (AMH). Accordingly, as a DOR woman under the age of 38, if normal sexual intercourse is achieved and the spouse factor is excluded, KM treatment, focusing on herbal medicine and acupuncture, can be applied. Conclusions: Korean Medicine treatment for infertility caused by decreased ovarian reserve is expected to be effective. However, research on specific treatments and targets will have to be added.

• Clinical and Experimental Reproductive Medicine
• /
• v.34 no.4
• /
• pp.229-238
• /
• 2007

• The Journal of Korean Obstetrics and Gynecology
• /
• v.37 no.1
• /
• pp.60-74
• /
• 2024

Objectives: This review aimed at investigating the research trends of animal experiment on the acupuncture for premature ovarian failure (POF). Methods: Studies were searched from PubMed, Cochrane Library, EMBASE, CINK, KISS, RISS, OASIS, KMBASE up to November 2023. Terms as POF, acupuncture, electroacupuncture were used. Results: Of 189 screened, 13 studies are selected and analyzed. The combined results showed that treatment group was effective of improving serum sex hormones level, ovarian morphology, expression related mRNA and protein compared with control group. The most frequently used acupoints were SP6, CV4. Conclusions: Included studies showed that acupuncture might have effect on POF. Further research should be conducted to verify its therapeutic mechanisms and effectiveness.

• Journal of Genetic Medicine
• /
• v.17 no.1
• /
• pp.47-50
• /
• 2020

In Turner syndrome (TS), 45,X/47,XXX mosaicism is a rare genotype. Due to its low frequency, the clinical features and prognosis are not clearly known. A 10-year-old girl was diagnosed with 45,X/47,XXX mosaicism TS and presented with short stature. She did not show any other TS phenotypic features, except for short stature, and developed spontaneous puberty and menarche, although she had unilateral ovarian agenesis. She achieved a significant growth improvement following growth hormone treatment. Since 45,X/47,XXX mosaic TS shows different gonadal function from that of classic TS, it is necessary to conduct surveillance for premature ovarian insufficiency.

• The Journal of Korean Obstetrics and Gynecology
• /
• v.32 no.4
• /
• pp.170-180
• /
• 2019

Objectives: The purpose of this study is to report the case of Korean medicine treatment on primary ovarian insufficiency. Methods: The patient in this case was 29-year-old female who was diagnosed with primary ovarian insufficiency. She had irregular menstruation and hypomenorrhea more than 6 months. She also suffered from hot flash and vaginal dryness. She was treated over 1 year with Korean medicine treatment, such as herbal medicine, acupuncture, and pharmacopuncture. We assessed the clinical symptoms, menstrual status and serum hormone level during the treatment. Results: After treatment, symptoms of primary ovarian insufficiency were relieved, level of serum FSH decreased and level of serum E2 increased. We maintained the treatment over 1 year and kept follow-up measurements of serum hormone level. Conclusions: This study shows that Korean medicine treatment can be effective in treating primary ovarian insufficiency. The report suggests the long treatment procedure for primary ovarian insufficiency.